Centro Respiratorio Infantil

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Asthma4 trials
• Chronic spontaneous urticaria2 trials
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 34 trials
• Phase 23 trials

Status

• Active, not recruiting3 trials
• Completed2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Celldex Therapeutics2 trials
• Connect Biopharm LLC1 trial
• Incyte Corporation1 trial
• Inmunotek S.L.1 trial
• Janssen Research & Development, LLC1 trial
• and 1 more

Running trials

• Active, not recruiting

  A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

  NCT07230860· Phase 2· Janssen Research & Development, LLC· Source

• Enrolling by invitation

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT07256392· Phase 3· Celldex Therapeutics· Source

• Recruiting

  Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

  NCT07348302· Phase 3· Inmunotek S.L.· Source

  Contact: Gabriel Gattolin

• Active, not recruiting

  A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT06445023· Phase 3· Celldex Therapeutics· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

  NCT05851443· Phase 2· Incyte Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• Chronic spontaneous urticaria1 recruiting

Closed trials

• Completed

  Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

  NCT06940141· Phase 2· Connect Biopharm LLC· Source

• Completed

  A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  NCT06664619· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source